Goto Shunsaku, Ohshima Tomotaka, Ishikawa Kojiro, Yamamoto Taiki, Nishizawa Toshihisa, Shimato Shinji, Kato Kyozo
1 Department of Neurosurgery, Kariya Toyota General Hospital, Kariya, Japan.
J Endovasc Ther. 2017 Aug;24(4):516-520. doi: 10.1177/1526602817716642.
To establish the safety and efficacy of the 7-F ExoSeal device for the closure of femoral puncture sites made by 8-F or 9-F introducer sheaths.
Between January 2013 and December 2016, 332 patients (mean age 68.4±12.1 years; 195 men) underwent neurointerventional procedures via percutaneous puncture of the common femoral artery and an 8-F (n=272, 81.9%) or 9-F (n=60, 18.1%) introducer. The access sites were sealed with a 7-F ExoSeal in all cases. Procedure success and closure-related complication rates were evaluated, and risk factors for complications were analyzed by comparing patient characteristics between those who did and did not experience complications.
Procedure success rates were 99.3% in the 8-F group and 100% in the 9-F group. The overall complication rate was 6.3% (n=17; all in the 8-F group), of which 13 (4.8%) were minor sequelae, including access-site hematoma (n=8), oozing (n=3), pseudoaneurysm (n=1), and retroperitoneal bleeding (n=1). Among the 4 (1.5%) major complications were 3 instances of bleeding requiring a blood transfusion and 1 surgical vascular repair. No complications were observed in the 9-F group. Patients who experienced complications had significantly longer activated clotting times (262±46 vs 218±55 seconds; p<0.001) compared with patients without complications.
A 7-F ExoSeal vascular closure device is safe and effective for the closure of femoral puncture sites made by 8-F or 9-F introducer sheaths.
评估7-F ExoSeal装置用于封闭由8-F或9-F血管鞘造成的股动脉穿刺部位的安全性和有效性。
2013年1月至2016年12月期间,332例患者(平均年龄68.4±12.1岁;男性195例)经皮穿刺股总动脉并使用8-F(n=272,81.9%)或9-F(n=60,18.1%)血管鞘进行神经介入手术。所有病例均使用7-F ExoSeal封闭穿刺部位。评估手术成功率和与封闭相关的并发症发生率,并通过比较发生和未发生并发症患者的特征分析并发症的危险因素。
8-F组手术成功率为99.3%,9-F组为100%。总体并发症发生率为6.3%(n=17;均在8-F组),其中13例(4.8%)为轻微后遗症,包括穿刺部位血肿(n=8)、渗血(n=3)、假性动脉瘤(n=1)和腹膜后出血(n=1)。4例(1.5%)严重并发症包括3例需要输血的出血和1例血管外科修复。9-F组未观察到并发症。与未发生并发症的患者相比,发生并发症的患者活化凝血时间明显更长(262±46秒对218±55秒;p<0.001)。
7-F ExoSeal血管封闭装置用于封闭由8-F或9-F血管鞘造成的股动脉穿刺部位是安全有效的。